文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气心脑血管急症

静脉-动脉体外膜氧合支持期间拔管的临床获益

Clinical Benefit of Extubation in Patients on Venoarterial Extracorporeal Membrane Oxygenation.
PubMed 文献 · Crit Care Med · 2021-09-27
一句话结论对静脉-动脉ECMO的难治性心源性休克患者,ECMO支持期间拔管安全可行,与更多无ICU天数相关。

倾向评分重叠权重分析后,拔管组30天内无ICU天数显著高于未拔管组(22天 vs 18天,p=0.036),呼吸机相关性肺炎和30天全因死亡率无差异。次要分析全体641例结果一致,拔管组无ICU天数更多且30天死亡风险更低。结论认为ECMO支持期间拔管安全可行,与更多无ICU天数相关。

要点

  • 拔管组30天内无ICU天数显著多于未拔管组(22天[11-26] vs 18天[7-25],p=0.036)。
  • 拔管组与未拔管组呼吸机相关性肺炎(OR 0.96,95%CI 0.51-1.82)和30天全因死亡率(5% vs 17%,HR 0.54,95%CI 0.19-1.59)无显著差异。
  • 入院时较高的简化急性生理评分II与拔管概率降低相关(OR 0.97,95%CI 0.95-0.99,p=0.008)。

适用人群与场景

  • 接受静脉-动脉体外膜氧合支持的难治性心源性休克患者,来自三家ICU(1500张床位的三级大学医院)。
  • 主要分析纳入344例成功撤除ECMO的患者;次要分析纳入全体641例静脉-动脉ECMO支持患者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 拔管患者中25%因呼吸、神经或血流动力学原因需要紧急再插管。

研究设计与关键结果

  • 研究类型:回顾性队列研究,采用倾向评分重叠权重分析;设置:三家ICU;主要分析人群:344例成功撤机的静脉-动脉ECMO患者。
  • 主要分析:拔管组与未拔管组呼吸机相关性肺炎(OR 0.96,95%CI 0.51-1.82,p=0.90)和30天全因死亡率(5% vs 17%,HR 0.54,95%CI 0.19-1.59,p=0.27)无显著差异。
  • 次要分析(全体641例):拔管组无ICU天数更多(18天[0-24] vs 0天[0-18],p<0.001),30天死亡风险更低(HR 0.45,95%CI 0.29-0.71,p=0.001)。
  • 拔管预测因素:入院时较高的简化急性生理评分II与拔管概率降低相关(OR 0.97,95%CI 0.95-0.99,p=0.008);心脏外科ICU插管与拔管概率增加相关(OR 3.14,95%CI 1.21-8.14,p=0.018)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究,采用倾向评分重叠权重分析;局限:原文未明确提及,但设计本身为回顾性、单中心(三家ICU同一医院)、样本量有限。

对床旁实践的改变

  • 对于静脉-动脉ECMO支持的难治性心源性休克患者,在成功撤机前可考虑拔管,拔管与更多无ICU天数相关,且不增加呼吸机相关性肺炎或30天死亡率。
  • 拔管后需注意约25%的患者可能因呼吸、神经或血流动力学原因需要紧急再插管,应做好再插管准备。
  • 入院时简化急性生理评分II较高的患者拔管可能性较低,临床决策时需综合考虑。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Although patients on venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock are usually supported with mechanical ventilation, it is not clear whether sedation cessation and extubation might improve outcomes.

DESIGN: Retrospective cohort study with propensity score overlap weighting analysis.

SETTING: Three ICUs in a 1,500-bed tertiary university hospital.

PATIENTS: From an overall cohort of 641 patients with venoarterial-extracorporeal membrane oxygenation support, the primary analysis was performed in 344 patients who had been successfully decannulated in order to reduce immortal time bias.

MEASUREMENTS AND MAIN RESULTS: Seventy-five patients (22%) were extubated during extracorporeal membrane oxygenation support and were subsequently decannulated alive. Forty-nine percent received noninvasive ventilation, and 25% had emergency reintubation for respiratory, neurologic, or hemodynamic reasons. Higher Simplified Acute Physiology Score II at admission (odds ratio, 0.97; 95% CI [0.95-0.99]; p = 0.008) was associated with a lower probability of extubation, whereas cannulation in cardiac surgery ICU (odds ratio, 3.14; 95% CI [1.21-8.14]; p = 0.018) was associated with an increased probability. Baseline characteristics were well balanced after propensity score overlap weighting. The number of ICU-free days within 30 days of extracorporeal membrane oxygenation decannulation was significantly higher among extubated patients compared with nonextubated patients (22 d [11-26 d] vs 18 d [7-25 d], respectively; p = 0.036). There were no differences in other outcomes including ventilator-associated pneumonia (odds ratio, 0.96; 95% CI [0.51-1.82]; p = 0.90) and all-cause mortality within 30 days of extracorporeal membrane oxygenation decannulation (5% vs 17%; hazard ratio, 0.54; 95% CI [0.19-1.59]; p = 0.27).As a secondary analysis, outcomes were compared in the overall cohort of 641 venoarterial extracorporeal membrane oxygenation-supported patients. Results were consistent with the primary analysis as extubated patients had a higher number of ICU-free days (18 d [0-24 d] vs 0 d [0-18 d], respectively; < 0.001) and a lower risk of death within 30 days of extracorporeal membrane oxygenation cannulation (hazard ratio, 0.45; 95% CI [0.29-0.71]; p = 0.001).

CONCLUSIONS: Extubation during venoarterial-extracorporeal membrane oxygenation support is safe, feasible, and associated with greater ICU-free days.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Massart N, Mansour A, Flecher E, et al. Clinical Benefit of Extubation in Patients on Venoarterial Extracorporeal Membrane Oxygenation. Crit Care Med. 2021. PMID: 34582413. doi:10.1097/CCM.0000000000005304

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。